Form D · Biotechnology

CNine Biosolutions, LLC

Birmingham, AL · CIK 0001725170

Offering snapshot reported Nov 8, 2018 · SEC filing

Reported sold
$1.6M
Offering amount: $2M
Investors reported
9
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Dec 11, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$800K$1.6MDec 13, 2017: $400,000.00Dec 13, 2017Nov 8, 2018: $1,600,000.00Nov 8, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$400,000 → $1,600,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 8, 2018Amendment$1,600,000$1,200,000vs Dec 13, 20179SEC filing
Dec 13, 2017Initial$400,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-300562
Total remaining to be sold is committed by participating investors, but such purchase is subject to the achievement of certain defined milestone events

Source: Form D, filed Nov 8, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott R. Barnum Director, Executive
James M. Johnston Executive
Baird Oldfield Director
Theresa N. Schein Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1040 31 St Street South
Birmingham, AL, 35205